rs1377265507

Variant names:

• chr1-243126601-T-C
• rs1377265507
• NM_014812.3:c.4603A>G

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_Strong BS2

The NM_014812.3(CEP170):​c.4603A>G​(p.Thr1535Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000422 in 1,423,006 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

• Frequency:
  • Genomes: not found (cov: 31)
  • Exomes 𝑓: 0.0000042 (0 hom.)
• Consequence: CEP170 NM_014812.3 missense
• Clinical Significance: Uncertain significance criteria provided, single submitter U:1
• Conservation: PhyloP100: 0.465
• Publications: 0 publications found

Genes affected

CEP170 (HGNC:28920): (centrosomal protein 170) The product of this gene is a component of the centrosome, a non-membraneous organelle that functions as the major microtubule-organizing center in animal cells. During interphase, the encoded protein localizes to the sub-distal appendages of mature centrioles, which are microtubule-based structures thought to help organize centrosomes. During mitosis, the protein associates with spindle microtubules near the centrosomes. The protein interacts with and is phosphorylated by polo-like kinase 1, and functions in maintaining microtubule organization and cell morphology. The human genome contains a putative transcribed pseudogene. Several alternatively spliced transcript variants of this gene have been found, but the full-length nature of some of these variants has not been determined. [provided by RefSeq, Jul 2008]

ENSG00000227230 (HGNC:):

ACMG classification

Our verdict: Benign. The variant received -8 ACMG points.

• BP4: Computational evidence support a benign effect (MetaRNN=0.045288324).
• BS2: High AC in GnomAdExome4 at 6 AD gene.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
CEP170	NM_014812.3	c.4603A>G	p.Thr1535Ala	missense_variant	Exon 20 of 20	ENST00000366542.6	NP_055627.2

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
CEP170	ENST00000366542.6	c.4603A>G	p.Thr1535Ala	missense_variant	Exon 20 of 20	5	NM_014812.3	ENSP00000355500.1
CEP170	ENST00000366544.6	c.4309A>G	p.Thr1437Ala	missense_variant	Exon 19 of 19	5		ENSP00000355502.1
CEP170	ENST00000366543.5	c.4231A>G	p.Thr1411Ala	missense_variant	Exon 19 of 19	5		ENSP00000355501.1

Frequencies

GnomAD3 genomes Cov.: 31

GnomAD2 exomes AF: 0.0000169 AC: 3 AN: 177700 AF XY: 0.0000106

Gnomad AFR exome AF: 0.00

Gnomad AMR exome AF: 0.000114

Gnomad ASJ exome AF: 0.00

Gnomad EAS exome AF: 0.00

Gnomad FIN exome AF: 0.00

Gnomad NFE exome AF: 0.00

Gnomad OTH exome AF: 0.00

GnomAD4 exome AF: 0.00000422 AC: 6 AN: 1423006 Hom.: 0 Cov.: 31 AF XY: 0.00000284 AC XY: 2 AN XY: 704014

African (AFR) AF: 0.00 AC: 0 AN: 32688

American (AMR) AF: 0.000157 AC: 6 AN: 38106

Ashkenazi Jewish (ASJ) AF: 0.00 AC: 0 AN: 25394

East Asian (EAS) AF: 0.00 AC: 0 AN: 37956

South Asian (SAS) AF: 0.00 AC: 0 AN: 81642

European-Finnish (FIN) AF: 0.00 AC: 0 AN: 51240

Middle Eastern (MID) AF: 0.00 AC: 0 AN: 5714

European-Non Finnish (NFE) AF: 0.00 AC: 0 AN: 1091218

Other (OTH) AF: 0.00 AC: 0 AN: 59048

GnomAD4 genome Cov.: 31

Alfa AF: 0.00 Hom.: 0

Bravo AF: 0.00000756

ClinVar

Significance: Uncertain significance

Submissions summary: Uncertain:1

Revision: criteria provided, single submitter

Submissions by phenotype

not specified Uncertain:1

Apr 25, 2022

Ambry Genetics

Significance: Uncertain significance

Review Status: criteria provided, single submitter

Collection Method: clinical testing

The c.4603A>G (p.T1535A) alteration is located in exon 20 (coding exon 19) of the CEP170 gene. This alteration results from a A to G substitution at nucleotide position 4603, causing the threonine (T) at amino acid position 1535 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
AlphaMissense	Benign	0.057
BayesDel_addAF	Benign	-0.41	T
BayesDel_noAF	Benign	-0.60
CADD	Benign	15
DANN	Benign	0.92
DEOGEN2	Benign	0.0061	T;.;.;.;T
Eigen	Benign	-0.73
Eigen_PC	Benign	-0.61
FATHMM_MKL	Benign	0.18	N
LIST_S2	Benign	0.65	.;.;.;T;T
M_CAP	Benign	0.0032	T
MetaRNN	Benign	0.045	T;T;T;T;T
MetaSVM	Benign	-1.1	T
MutationAssessor	Benign	0.0	N;.;.;.;.
PhyloP100		0.47
PrimateAI	Benign	0.35	T
PROVEAN	Benign	-0.44	N;N;N;N;N
REVEL	Benign	0.10
Sift	Benign	0.27	T;T;T;T;T
Sift4G	Benign	0.76	T;T;T;T;T
Polyphen		0.0	B;B;B;.;.
Vest4		0.067
MutPred		0.062		Loss of glycosylation at T1535 (P = 0.0085);.;.;.;.;
MVP		0.29
ClinPred		0.028	T
GERP RS		-0.37
Varity_R		0.014
gMVP		0.36
Mutation Taster		=89/11	polymorphism

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Other links and lift over

dbSNP: rs1377265507; hg19: chr1-243289903;